EMA sounds its own safety alarm for Pfizer blockbuster, but they’re also not forcing a limit on dosing — yet

The European Medicines Agency has issued a formal warning for patients and physicians to stick with the recommended dose of Xeljanz for treating rheumatoid arthritis and to watch out for potentially lethal blood clots.